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The aetiology of childhood asthma is complex. An early dysfunction in the immunological development of the
innate immune system in combination with environmental factors possibly triggers asthma. CD14 and toll-like
receptors are important components of the innate immune system. The aim of this systematic review was to obtain
a better insight into the relation between CD14 and toll-like receptors and childhood asthma in Caucasians. We
searched PubMed and EMBASE for relevant articles. In total, 44 articles were included. The quality of the selected
studies was independently assessed by the first two authors using the Newcastle-Ottawa quality assessment scale.
Toll-like receptor 2, toll-like receptor 6, toll-like receptor 9, and toll-like receptor 10 appear to have some association
with childhood asthma in Caucasians. The evidence for a relation of CD14 with childhood asthma is limited. In
conclusion, there is no convincing evidence yet for a role of CD14 and toll-like receptors in relation to childhood
asthma. Future studies should include haplotype analysis and take environmental factors into account to further
clarify the role of CD14 and toll-like receptors on childhood asthma.
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Background
Asthma is a common disease in childhood and is cha-
racterized by chronic eosinophilic airway inflammation
and airway (hyper) responsiveness [1]. Both, genetic and
environmental factors have been associated with asthma.
The cumulative effect of these factors is large, though the
individual contribution of each factor may be limited
[2-6]. Also, genetic and environmental factors can modu-
late each other. As this modulation can differ with age, it
can be time dependent [3]. Hence, the aetiology of child-
hood asthma is complex.
It is expected that an early dysfunction in the immuno-
logical development of the innate immune system, in
combination with environmental factors may trigger
childhood asthma [7]. The innate immune system makes
the first contact with pathogens. Genetic variations in
components of the innate immune system can alter the
capability to deal with pathogens. The direction of the in-
nate immune system response can depend on presented* Correspondence: e.klaassen@maastrichtuniversity.nl
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reproduction in any medium, provided the orenvironmental signals, like endotoxin exposure [8]. The
difference in genetic make-up combined with differences
in environmental factors leads to variations in the immune
response. Important components of the innate immune
system are CD14, an adaptor molecule, and a system of
pathogen receptors named toll-like receptors (TLRs) [9].
CD14 is a multifunctional high-affinity receptor for
endotoxins, lipopolysaccharides and other bacterial wall
components. It has been implicated in the development
and maturation of the innate immune system [10-13].
Several studies have associated CD14 with determination
of the balance between Th1 versus Th2 cytokines [14-16].
It is expressed on the surface of monocytes, macrophages,
and neutrophils and occurs as a membrane-bound form
and a soluble form [17,18]. Polymorphisms in CD14 and
levels of soluble CD14 (sCD14) have been implicated in
childhood asthma [10,19-23].
TLRs are evolutionarily conserved receptor complexes
in the pathogen-recognition process [24]. Each of the
ten TLRs described in humans recognizes a different
spectrum of pathogen-associated molecular conforma-
tions. After interaction with pathogens, TLRs induce the
innate immune response. They are involved in balancing
Th1 versus Th2 immune responses, shifting the balancel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mune cells such as antigen-presenting cells, and in epithe-
lial cells [24]. Polymorphisms in TLRs have been linked to
childhood asthma [25-28].
In this systematic review we summarize research on
CD14 and TLRs in relation to asthma in Caucasian chil-
dren. By selecting this specific group we expect more
clarity in study outcome as conclusions can differ between
ethnicities [29]. Consequently, a better insight into the
relation between CD14 and TLRs and pathology of child-
hood asthma in Caucasians would be achieved. Further,
we analyzed the effect of environmental factors on the re-




PubMed and EMBASE were searched for relevant articles
up to October 2012 by two independent investigators.
Primary search terms (CD14, toll-like, TLR) were com-
bined with secondary search terms (asthma*, wheez*) and
limitation ‘child’ to find as many relevant publications as











































Figure 1 PRISMA flow diagram of search. The flow diagram depicts the
review. It maps out the number of records identified, included and excludein Caucasian children and investigated the relation with
CD14 or TLRs. Articles were excluded if the study popula-
tion was non-Caucasian (based on area where the study
was conducted and stated by the authors) or if the full text
was not available in English. Also, conference abstracts
and reviews were excluded. The articles were screened
by the first two authors for suitability first by title, later by
abstract, and finally by full text. In case of disagreement,
the senior author was asked to screen the article as well.
Additionally, some studies were identified by a manual
search of references of included studies. A PRISMA flow
diagram of the search is included in Figure 1 [30].
Quality assessment
The first two authors independently assessed the quality
of the selected studies. Quality assessment was carried
out using the Newcastle-Ottawa quality assessment scale
which has especially been developed for assessment of
observational studies in systematic reviews [31]. In case
criteria were met, a “*” was assigned. In case criteria were
not met, a “-” was assigned. The overall quality of each art-
icle was assessed as better than average (+), average (+/−),
or less than average (−). In case of disagreement theAdditional records identified
through other sources

























flow of information through the different phases of the systematic
d, and the reasons for exclusions.
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did not attempt to pool the data.
The categories for cohort studies were as follows: S1:
Representativeness of the exposed cohort, S2: Selection
of non-exposed cohort, S3: Ascertainment of exposure,
S4: Outcome of interest not present at start of study,
C1a/C1b: Comparability of cohorts on the basis of the
design or analysis, O1: Assessment of outcome, O2:
Duration of follow-up, O3: Adequacy of follow up. The
categories of case control studies were as follows: S1:
Case definition, S2: Representativeness of the cases,
S3: Selection of controls, S4: Definition of controls,
C1a/C1b Comparability of cases and controls on the basis
of the design or analysis, E1: Ascertainment of exposure,
E2: Same method of ascertainment for cases and con-
trols, E3: Non-response rate. As no cross-sectional
assessment tool was available in the Newcastle-Ottowa
quality assessment scale, cross-sectional studies (as identi-
fied in the method section of the respective article)
were assessed in both the cohort scale and the case
control scale. Nested case control studies were scored as
case control studies. Polymorphisms, gene expression
and/or levels were analyzed by a standard method in all
studies. Therefore ascertainment of exposure (S3 for
cohorts, E1 and E2 for case control studies) was only
scored in case of exposure to environmental factors.
Also, we assigned a “*” for E3 in case control studies ifTable 1 Quality scoring based on the Newcastle-Ottawa quali
First author Year S1 S2 S3
Bieli † [10] 2007 * * *
Bottema [26] 2010 * * NA
Custovic [62] 2011 * * -
Eder † [25] 2004 * * *
Ege † [22] 2007 * * *
Fageras Bottcher † [39] 2004 - * *
Guerra [11] 2004 * * -
Jones [48] 2002 - * NA
Kabesch † [13] 2004 * * NA
Kerkhof [56] 2010 * * *
Lange [63] 2011 * * NA
Lodrup Carlsen [51] 2010 * * NA
O’Donnell [36] 2004 * * NA
Reijmerink [41] 2010 * * NA
Rothenbacher [53] 2005 * * *
Simpson [8] 2006 * * *
Snijders † [52] 2006 * * *
Soferman [54] 2004 - * NA
S1: Representativeness of the exposed cohort, S2: Selection of non-exposed cohort,
study, C1a/C1b: Comparability of cohorts on the basis of the design or analysis, O1:
(*: criteria were met; -: criteria were not met); OQ: Overall quality (+ better than ave
applicable; † cross-sectional study.the non-response rate was mentioned. Five articles
could not be scored as they had neither cohort nor case
control or cross-sectional design [19,32-34].
Results
Of the 274 collected records, a total of 44 articles were
included in this study (Figure 1). Only one article was ex-
cluded based on language [35]. Characteristics of included
studies are provided in Additional file 1 (see Additional
file 1). The results of the quality scoring can be viewed in
Table 1 for cohort studies, and in Table 2 for case control
studies.
Limited evidence for a relation between polymorphisms
of CD14 and childhood asthma
The relation between childhood asthma and polymorphisms
in CD14 was studied in 17 studies [10,12,13,19-21,34,36-45].
In most studies asthma was taken as outcome. In two studies
asthma severity was taken as outcome [19,34]. Age ranged
from 0 up to 19 years of age. The number of cases varied
from 10 to 644, and controls from 115 to 1858 subjects.
CD14 rs2569190 polymorphism, also known as C-260T or
C-159T, was studied in 16 studies [10,12,13,19-21,34,36-
40,42-45]. Only one study found an association of this poly-
morphism with childhood asthma, showing an association
of the T allele with decreased asthma severity (Table 3)
[19]. For the rs4914 polymorphism an association wasty assessment scale: cohort studies
S4 C1a C1b O1 O2 O3 OQ
- * * - * - +/−
* - - - * - +/−
* * * - * * +
- * * - * - +/−
- * * - * - +/−
- * * * * - +/−
* * * - - - +/−
* - - - - - –
* - - - * - +/−
* * * - * - +
- * * * * - +
* * * - * * +
- * * - * * +
* - - - * - +/−
* * * - - * +
* * * - * * +
* * * - - * +
* * * * * * +
S3: Ascertainment of exposure, S4: Outcome of interest not present at start of
Assessment of outcome, O2: Duration of follow-up, O3: Adequacy of follow up
rage quality, +/− average quality, – less than average quality); NA = not
Table 2 Quality scoring based on the Newcastle-Ottawa quality assessment scale: case control studies
First author Year S1 S2 S3 S4 C1a C1b E1 E2 E3 OQ
Bieli † [10] 2007 - * * - * * * * * +
Bjornvold [38] 2009 */- * * * - - NA NA - +/−
Choudhry [40] 2005 - - * - * * - * - +/−
Daley [21] 2009 - */- * - - - NA NA - +/−
Eder † [25] 2004 - * * - * * * * - +/−
Ege † [22] 2007 - * * - * * * * * +
Fageras Bottcher † [39] 2004 * - - - * * * * - +/−
Genuneit [46] 2009 - * * */- * - NA NA - +/−
Heinzmann [12] 2003 * * * - - - NA NA - +/−
Heinzmann [58] 2010 * - * - - - NA NA - +/−
Hoffjan [61] 2005 - - - * - - NA NA - –
Hussein [59] 2012 * * - * - - NA NA - +/−
Jackola [23] 2006 * - * * * - NA NA - +/−
Kabesch † [13] 2004 - * * - - - NA NA - +/−
Kormann§ [27] 2008 * * * * * - NA NA - +
Kurowski [44] 2011 - - * - - - * * - –
Marcos [50] 2010 * - - * - - * - - –
Miedema§ [45] 2012 - - * * - - NA NA - +/−
Moller-Larsen [28] 2008 * - * * * - NA NA - +/−
Perin [42] 2011 * - - * - - NA NA - +/−
Puthothu [57] 2006 * - * - - - NA NA - +/−
Schubert [60] 2006 * - * - - - NA NA - +/−
Sengler § [37] 2003 - * * * * - NA NA - +/−
Snijders † [52] 2006 - * * * * * * * - +
Sorensen § [47] 2009 - * * * * * * * * +
Tremblay [20] 2008 - */- * - - - NA NA - +/−
Yang [55] 2004 - - * * * * NA NA - +/−
Zhang [43] 2011 * * * * * * * * - +
S1: Case definition; S2: Representativeness of the cases; S3: Selection of controls; S4: Definition of controls; C1a/C1b Comparability of cases and controls on the
basis of the design or analysis; E1: Ascertainment of exposure; E2: Same method of ascertainment for cases and controls; E3: Non-response rate (*: criteria were
met; -: criteria were not met); OQ: Overall quality (+: better than average quality, +/− average quality, – less than average quality); † cross-sectional study; § nested
case control study; NA = not applicable.
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two children cohorts (Study of Asthma Genetics and
Environment Cohort) included in one study (Table 3)
[20,21]. However, another study investigating rs4914
found no association [38]. All other polymorphisms
studied did not show any association with asthma
[10,12,20,21,38,40,41,43-45]. Partial duplication in studied
population and studied single nucleotide polymorphisms
was present between two studies [20,21].
In three studies the association between rs2569190 in
CD14 and wheeze was addressed [8,46,47]. The age of
the population studied varied from 18 months up to 13
years. One study investigated two additional polymor-
phisms (rs5744441 and rs5744455) [46]. None of thesestudies found a relationship between CD14 polymor-
phisms and childhood wheeze.
The relation between polymorphisms of CD14 and
childhood asthma can be influenced by environmental
exposures
The protective effect of farm milk consumption was in-
creased in carriers of one or, even more so, two major
alleles of rs2915863 [10]. Also, in individuals exposed to
tobacco smoke, a significant association was found
between rs2569190 and rs3776138 polymorphisms and
asthma severity [40]. Eastern (Russian) or Western (Finnish)
environment/lifestyles did not influence the relationship of
rs2569190 and rs5744455 on asthma ever in childhood [43].
Table 3 Single nucleotide polymorphisms with association with asthma
Gene rs-number Alleles Number of
associations
Minor allel related to Association ref. No association ref.
CD14 rs2569190 C > T 1 out of 15
(duplication [20,21])
decreased asthma severity [19] [10,12,13,20,21,34,
36-40,42-45]
CD14 rs4914 G > C 1 out of 2
(duplication [20,21])
decreased asthma incidence [20,21] [38]
TLR1 rs5743595 T > C 1 out of 1 atopic asthma [27] NA
TLR1 rs4833095 A > G 1 out of 1 atopic asthma [27] NA





TLR2 rs3804099 T > C 1 out of 6 (partial
duplication [26,56])
nonatopic asthma (inverse) [27] [25,26,38,45,56]
TLR2 rs3804100 T > C 1 out of 6 (partial
duplication [26,56])
allergic asthma (inverse) [38] [21,25,26,45,56]
TLR2 rs1898830 A > G 1 out of 4 asthma [26] [21,27,56]
TLR2 rs5743708 G > A 1 out of 2 asthma severity in atopic
children
[59] [43]
TLR4 rs2737190 A > G 1 out of 1 (non-atopic) asthma [27] NA
TLR4 rs4986790 A > G 3 out of 10 asthma, atopic asthma and
asthma severity in atopic children
[34,39,59] [41,43-45,55,56,60]
TLR4 rs4986791 C > T 1 out of 4 mild atopic asthma [34] [27,56,60]
TLR6 rs6531666 T > C 1 out of 1 asthma [45] NA
TLR6 rs5743789 T > A 1 out of 1 atopic asthma [27] NA
TLR6 rs5743798 C > T 1 out of 1 asthma [45] NA
TLR6 rs5743810 C > T 2 out of 5 (atopic) asthma [27,61] [21,45,57]
TLR7 rs179008 A > T 1 out of 2 asthma [28] [27]
TLR8 rs2407992 G > C 1 out of 1 asthma [28] NA
TLR9 rs187084 T > C 1 out of 3 asthma [27] [21,45]
TLR10 rs4129009 A > G 1 out of 2 atopic asthma inverse [27] [45]
TLR10 rs11096957 A > C 1 out of 3 asthma [21] [45,57]
Ref: reference, TLR: Toll-Like Receptor, NA: not applicable.
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mites or pollens, and exposure to cats and dogs or other large
animals in combination with rs5744454, rs2569190 and
rs3776138 and asthma-related traits [40], nor dust or living
area (rural or urban) with rs2569190 or rs3138078 and
asthma [44]. Finally, a dose-dependent relation of endo-
toxin with non-atopic wheeze for individuals with homo-
zygosity of the major allele of rs2569190 was shown [8].
The association between smoking or pet keeping and the
risk of recurrent wheeze was not affected by the rs2569190
polymorphism [47].
Polymorphisms in CD14 lead to increased levels of sCD14
Several studies have shown that sCD14 levels are
higher in the presence of one or two minor allele(s)
of rs2569190 in chronic and also acute asthma in
children [8,13,19,33]. In addition, during asthma at-
tacks an inverse correlation was shown between
asthma severity scores and the log value of sCD14 forthe major allele of rs2569190 [19]. No significant as-
sociation was found between rs574441, rs2569193,
and rs2569190 and gene expression of CD14 [10].
Higher levels of sCD14 are related to childhood asthma
depending on disease status and time of measurement
Levels of sCD14 in cord blood were significantly higher
in children with transient-atopy (positive skin prick test
at two years of age but not at five years of age and with-
out asthma), compared with never-atopic or persistent-
atopic children. However, no changes between transient-
atopy, never-atopic or persistant-atopic children could
be shown in plasma sCD14 at six months, one year, and
five years of age [48]. Also, levels of sCD14 were signifi-
cantly higher during acute asthma attacks than at recov-
ery in children with status asthmaticus [32]. However,
these results might be biased by the administration of
corticosteroids during the acute stage which might have
caused suppression of cell activation, thereby reducing
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association of sCD14 levels with asthma as measured
in cord blood, serum or bronchoalveolar lavage fluid
[23,50,51]. In one study no association of sCD14 levels
in breast milk with wheeze was found [52].
(Expression) levels of (s)CD14 can be related to
environmental exposures leading to a different disease
risk
One study showed that of the protective farm related
factors that were associated with asthma (pig farming,
farm milk consumption, frequent stay in animal sheds,
and child’s involvement in haying), only being a farm
child in general was associated with higher expression
levels of CD14 [22]. Breastfed children who received
breast milk with high sCD14 levels had less chance to
develop asthma, reaching statistical significance in chil-
dren of mothers with no history of atopic disease [53].
Another study showed that age or gender did not influ-
ence sCD14 production in asthmatic families [23].
CD14 serum levels in infants without recurrent wheez-
ing was significantly higher than in wheezing infants,
twelve months after hospitalization due to RSV-induced
bronchiolitis. Also, in hospitalized patients sCD14 levels
increased with age of admission [54].
Overall, results suggest that some environmental expo-
sures like being a farm child or breast milk with high
sCD14 levels protect against development of asthma,
however, the number of studies is limited.
Some evidence for a relation between polymorphisms of
TLRs (2, 6, 9, 10) and childhood asthma
Childhood asthma in relation to polymorphisms in TLRs
was addressed in 19 studies [21,25-28,34,38,39,41,43-45,
55-61]. The age of the population in these studies ranged
from 0 to 18 years with 31 to 644 cases and 184 to 2927
controls. Outcome was defined as atopic/allergic asthma,
non-atopic asthma, bronchial asthma, current asthma
symptoms or asthma in general.
TLR4 is by far the most studied of all TLRs in relation
to asthma in children, but only some studies showed an
association (Table 3). Rs4986791 was statistically more fre-
quent in mild atopic asthmatics [34], whereas rs2737190
showed an association with asthma in general and also
non-atopic asthma [27] Rs4986790 showed no association
with asthma in seven studies [41,43-45,55,56,60], but was
associated with symptoms of (atopic) asthma in two other
studies [34,39]. Also, rs4986790 was associated with in-
creased asthma severity in atopic children [59]. However,
in most studies polymorphisms of TLR4 did not show any
association with asthma [21,25,27,38,41,44,45,55,56,59,60].
Some duplication between the studies of Reijmerink et al.
and Kerkhof et al. was present as the same population was
used for single nucleotide polymorphism analysis [41,56].Studied polymorphisms in the study of Reijmerink were
not specified [41].
TLR2, TLR6, TLR9, and TLR10 have been associated
with asthma in several studies. For TLR2, rs4696480,
rs3804099, rs3804100, and rs1898830 showed associ-
ation with childhood asthma in a number of studies, but
not in others (Table 3) [21,25-27,38,43,56,62]. Moreover,
rs5743708 was associated with increased asthma severity
in atopic children (Table 3) [59]. Finally, rs13150331,
rs4696483, rs5743704, rs7656411, rs1339, rs2289318,
and rs5743708 showed no association with childhood
asthma [21,43,59]. Two studies had an overlap in data
[26,56]. For TLR6, rs6531666, rs5743789, rs5743798,
and rs5743810 significant associations with asthma and
atopic asthma were found, but not with asthma in other
studies (Table 3) [21,27,45,57,61]. Haplotype spanning of
polymorphisms in TLR6 and TLR10 (see TLR10) re-
vealed an association with childhood asthma, indicating
no individual but a combined influence of these poly-
morphisms on asthma in children [21,57]. Other TLR6
polymorphisms were not associated with asthma in chil-
dren [21,27,45]. For TLR9, rs187084 showed a positive
association with childhood asthma (Table 3) [27], but
not in all studies [21,45]. Other polymorphisms revealed
no association with childhood asthma [21,27,44,45,
60,63]. For TLR10, out of the eight studied polymor-
phisms, rs4129009 and rs11096957 showed association
with (atopic) asthma in some studies (Table 3) [21,27,
45,57]. The rs11096957 polymorphism only demon-
strated association in one of the two children cohorts
(Study of Asthma Genetics and Environment Cohort)
studied by Daley et al [21]. Several polymorphisms
(rs4274855, rs10856839, rs11096957, rs11096956,
rs11096955, rs11466657, rs4219009) showed no indi-
vidual association with bronchial asthma, however,
haplotype spanning together with polymorphisms in
TLR6 (rs5743794, and rs5743810) did [57]. Also
rs4274855, rs10856839, rs11096957, and rs4129009
demonstrated a haplotype-based association [58].
TLR7 and TLR8 were only studied in two studies and
TLR1, TLR3, and TLR5 in one study: For TLR7, associa-
tions with asthma phenotypes for rs179008 separately,
and rs179008, rs5743781, rs864058 haplotypes were
observed in one study, however, rs179008 showed no
association in another study (Table 3) [27,28]. For TLR8,
association with asthma phenotype in childhood
was shown for rs2407992 separately, and rs5741883,
rs3764879, rs3764880, rs5744077, rs2159377, and
rs2407992 haplotypes, but not rs3761624 (Table 3)
[27,28]. For TLR1, rs5743595, rs4833095, and not
rs5743594 showed significant inverse effects with ato-
pic asthma in childhood (Table 3) [27]. For TLR3,
rs3775291 showed no association with childhood
asthma [27]. Also, rs5744168, rs2072493 and rs5744174
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hood asthma [27].
One study with 1105 cases and 3137 controls aged 8
to 12 years used wheeze in the past 12 months as
outcome variable [46]. For TLR4, rs11536896 showed
association, but three other polymorphisms did not. In
TLR2, rs1898830 showed association with more frequent
wheeze. For TLR9, out of the three studied poly-
morphisms, rs187084 showed positive association with
wheeze.
The relation between polymorphisms of TLRs and
childhood asthma is dependent on environmental
influences
Four studies addressed the relation between TLR poly-
morphisms and environmental exposure on childhood
asthma [25,43,44,56]. The polymorphisms rs4696480 and
rs1898830 in TLR2 and the polymorphisms rs2770150,
rs10759931, rs6478317, rs10759932, and rs1927911 in
TLR4 increased the effect of fine particulate matter ex-
posure on the prevalence of doctor-diagnosed asthma
from birth up to eight years of age. Polymorphism
rs10759931 in TLR4 showed an interaction between
childhood asthma symptoms and air pollutant levels [56].
High or low endotoxin exposure revealed no interaction
with rs4696480, rs3804099, and rs3804100 in TLR2
for asthma diagnosis or current asthma symptoms in
children [25]. There was no relation between TLR2
rs5743708 or TLR4 rs4986790 on asthma ever when
Eastern or Western environment was taken into account
[43]. A relationship neither existed for TLR4 rs4986790
or TLR9 rs352140 with asthma when dust or area (rural/
urban) was taken into account [44].
Also, for polymorphism rs4696480 in TLR2 a signifi-
cant interaction was shown with day care attendance on
the development of atopic wheeze in a longitudinal ana-
lysis from birth until the age of five years [62].
Polymorphisms in TLRs relate to an increased gene
expression of TLRs
Minor alleles of TLR1 rs5743595, TLR6 rs5743789, and
TLR10 rs4129009 polymorphisms were associated with
increased mRNA expression of the respective TLRs in
children [27]. In asthmatic children, farm related factors in
combination with TLR polymorphisms were related to
higher expression levels of respective TLRs in children [22].
Discussion
We reviewed the literature on the relationship between
CD14 and TLRs (polymorphisms) and asthma in Caucasian
children. Although a number of studies suggest such a
relation, the reviewed literature does not provide con-
vincing evidence for a significant direct role of CD14.TLR2, TLR6, TLR9, and TLR10 did show moderate as-
sociation with asthma in childhood, but TLR4 did not.
CD14 rs2569190 may be exemplary for the relevance of
polymorphisms in relation to asthma. This polymorphism
has been analysed in two meta-analysis [64,65]. No signifi-
cant overall association was detected between rs2569190
and asthma. However, when analysis was stratified by
atopy, there was an association indicating a protective ef-
fect of the T-allele of rs2569190 in relation to atopic
asthma [65]. This was also the case when the analysis was
stratified by atopy and restricted to children [64]. How-
ever, these results should be interpreted with caution be-
cause of the exclusion of studies and the small sample
sizes. Also, as the current review was restricted to Caucasian
children, comparison is difficult. The lack of similarity
in the set-up and populations of these studies makes
deduction of conclusions difficult, even more so if the
complexity of the disease is taken in account.
Although some TLRs showed associations with asthma
in childhood, the most investigated TLR4 did not. A
possible explanation is that TLR4, contrary to TLR2,
TLR6, TLR9 and TLR10, mainly plays a role in immune
response to gram-negative bacteria [25,61]. As the other
TLRs are involved in the immune response to multiple
microbial products, it can be expected that their role in
heterogeneous symptoms and/or diseases is easier to es-
tablish than TLR4 [25,27,56,61].
Since CD14 and TLRs are the first mediators in the re-
sponse of the innate immune system, it is plausible that
their contribution to asthma development is influenced
by environmental conditions. An increasing number of
association studies have included such conditions. How-
ever, up to now, the evidence for an interplay between
environment and polymorphisms of the mentioned
genes is scanty and based on few observations only. If
important environmental factors are not included, asso-
ciations might be overlooked or misinterpreted. For ex-
ample, it has been demonstrated that the direction of
the relation between a CD14 polymorphism and asthma
was dependent on endotoxin exposure [8]. Also interest-
ing is the fact that sCD14 in serum seems to be in-
creased at specific time points, which might indicate a
time window at which children are more vulnerable for
exposure [54]. Consequently, increasing the number of
populations studied, without inclusion of environmental
influences, will not guarantee more valid results. Indeed,
one may argue that studies not taking environmental in-
fluences into account underestimate the complexity of
the disease.
Another important development in recent years is the
focus on haplotype analysis instead of individual poly-
morphisms [66-68]. It has been shown that the com-
bined analysis of several polymorphisms by haplotypes
increases the power to detect associations. In this review,
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since in these studies individual polymorphisms did not
provide an association, whereas haplotype spanning did
[57,58]. Consequently, our insight into the role of CD14
and TLRs in relation to asthma would benefit from
haplotype analysis. Application of this method will not
demand a major investment since previous collected
study populations can be reused.
Our review has several strengths. Firstly, by systematic
evaluation of the available literature, our review provides
an efficient and comprehensive summary of CD14 and
TLRs polymorphisms in relation to childhood asthma.
Secondly, to increase the number of articles included, we
choose to include studies with various outcome measures
of asthma. Thirdly, independent searching and scoring of
articles was performed to come to a balanced opinion.
Also, no articles were rejected based on assigned score, as
there is no general agreement on evaluation of observa-
tional studies [69]. Fourthly, we decided to focus on
asthma as outcome measure as it is a more established en-
tity than for example wheeze. While some studies only
used parent reported diagnosis, other studies used more
objective methods like doctor diagnosis and lung function
[10,12,23,36,38,56]. However, as wheeze is a good pre-
dictor in older age for presence of asthma we included
studies with outcome wheeze in our review as well.
Though, we did separate the used definitions as the under-
lying mechanisms can differ. Finally, contrary to most re-
views, the population included is restricted to Caucasian
children.
Some limitations need to be mentioned. Firstly, the
number of articles on this subject is limited. Secondly,
the wide scatter in age within and between studies may
lead to difficulties in interpretation of results due to such
factors as behaviour and environment. Thirdly, as is the
case for most reviews, the comparability between the
studies was diminished by methodological differences
between the studies.
Conclusions
All studies taken together, no clear role for CD14 and
TLRs in childhood asthma can be determined based on
this review. This is probably due to unknown underlying
confounding or mediating environmental factors. Another
reason can be the fact that analysis has mostly been
performed on individual polymorphisms instead of haplo-
type spanning. Therefore, planning future studies should
include haplotype analysis and take environmental factors
into account. Also, to be able to identify and confirm asso-
ciations and gene-gene and gene-environmental interac-
tions with sufficient power, large populations will be
necessary. If the above mentioned suggestions are taken
into consideration, future studies on the role of CD14 and
TLRs in childhood asthma may be more successful.Additional file
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